The ASCO Rally For Biotech Stocks Is On: Now We Need To Consolidate Recent Gains Next Week

Every year the ASCO Meeting excites investors because of clinical data being presented on a huge pipeline of oncology products. High expectations have already delivered an ASCO rally so now can the actual clinical data support these gains?